Filing status
- Accounts due
- 30 June 2027
- Last accounts
- 30 September 2025
- Conf. stmt due
- 12 May 2027
- Last conf. stmt
- 28 April 2026
DE Novo Pharmaceuticals Limited
- Incorporated
- 28 April 1999 (27 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Amit Agarwal
- Owned by
- Farhad Fahid
- Accounts type
- Micro entity
- Region
- South East
- Address
- Gilmarde House47 South Bar StreetBanburyOX16 9AB
Charges
- Total
- 3
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 3
Officers 2 active
Officer details are public data from the Companies House register.
Agarwal, Amit
Director · Appointed 2 June 2015
British
Born April 1976 (50)
British
Born March 1959 (67)
Officer history (23 former)
29 April 2024
2 June 2015
Appointed Agarwal, Amit as Director
5 November 2014
5 November 2014
18 August 2013
17 October 2008
30 September 2008
23 July 2008
11 April 2008
Resigned Wegter, Marcus Antonius as Director
18 December 2007
1 July 2007
23 March 2007
Appointed Wegter, Marcus Antonius as Director
10 November 2006
17 September 2006
14 September 2005
Resigned Ashton, Michael John, Dr as Director
14 June 2005
14 June 2005
14 June 2005
14 June 2005
Resigned Van Der Have, Frederik Vincent as Director
22 April 2005
Resigned Wuurman, Bart as Director
16 June 2004
Resigned Beasley, Steven Colin, Dr as Director
5 April 2004
5 April 2004
3 November 2003
Appointed Wuurman, Bart as Director
20 October 2003
20 October 2003
31 May 2002
8 November 2001
Appointed Beasley, Steven Colin, Dr as Director
26 July 2001
26 July 2001
Resigned Beasley, Steven Colin, Dr as Director
26 July 2001
Appointed Van Der Have, Frederik Vincent as Director
26 July 2001
26 July 2001
23 March 2001
Appointed Beasley, Steven Colin, Dr as Director
23 March 2001
27 October 2000
Appointed Ashton, Michael John, Dr as Director
22 September 2000
22 September 2000
5 April 2000
5 April 2000
5 April 2000
3 September 1999
3 September 1999
3 September 1999
3 September 1999
3 September 1999
28 April 1999
28 April 1999
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
British
Born March 1959 (67)
Former controllers (1)
15 June 2023
Ceased Merlin Residual Investments Limited — Owns 75–100% of shares
Financials
Balance sheet as at 30 September 2025 · micro entity accounts
- Net Assets
- £21,365
- Employees
- 2
- Current Ratio
- 26.3x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Current Assets | £53,991 | £56,394 | £61,610 | £64,488 | £35,345 | £5,971 |
| Debtors | £30 | £30 | £30 | |||
| Cash | £64,458 | £35,315 | £5,941 | |||
| Creditors (< 1 year) | £2,051 | £1,427 | (£1) | £29,705 | £329 | £150 |
| Net Current Assets | £51,990 | £55,017 | £61,611 | £34,783 | £35,016 | £5,821 |
| Net Assets | £21,365 | £24,392 | £30,236 | |||
| Shareholder Funds | £21,365 | £24,392 | £30,236 | £34,783 | £35,016 | £5,821 |
| Turnover | £0 | £0 | ||||
| Admin Expenses | £238 | £225 | ||||
| Operating Profit | (£238) | (£225) | ||||
| Profit Before Tax | (£233) | (£213) | ||||
| Tax | £0 | £0 | ||||
| Profit for Period | (£233) | (£213) | ||||
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 19 June 2026 | Confirmation statement with updates | 28 April 2026 | 8 | |
| 14 November 2025 | Micro company accounts | 30 September 2025 | ||
| 27 October 2025 | Director's details changed | 2 | ||
| 24 October 2025 | Change of details for a person with significant control | 2 | ||
| 6 May 2025 | Confirmation statement with updates | 28 April 2025 | 8 |
Some other companies at this address
Other companies in this industry
Kidlington
Kidlington
Middlesex
Manchester
Hartley Wintney
Pampisford
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →